Rocket Lab Shares Tumble as Neutron Delay Overshadows Record Results

Despite posting what appeared to be stellar third-quarter figures, Rocket Lab USA saw its stock price plummet. The market’s harsh reaction, a drop of approximately 40% from recent highs, was triggered not by past performance but by a significant postponement of its future-facing Neutron rocket program, casting doubt on the company’s ambitious growth trajectory.

Operational Excellence Meets Market Disappointment

The core business of Rocket Lab is demonstrating remarkable strength. The company reported a record $155 million in revenue for the third quarter, a surge of 48% that surpassed Wall Street’s expectations. Operational efficiency was also better than anticipated, with a loss per share of just $0.03, significantly lower than the projected $0.10 loss.

The Launch Services division was a particular standout, nearly doubling its revenue. Financially, the company appears on solid ground, boasting a cash position exceeding one billion dollars and a substantial backlog of orders valued at over $1.1 billion.

The Neutron Setback: A Blow to Future Ambitions

This robust operational performance was entirely eclipsed by a single announcement: the maiden launch of the Neutron rocket has been delayed. Initially scheduled for late 2025, the launch is now pushed to 2026. This project is central to Rocket Lab’s long-term strategy, designed to grant it access to the lucrative medium-payload market and enable direct competition with industry giants like SpaceX.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

The delay has ignited investor concerns about escalating development costs. The fear is that the Neutron program will consume significantly more capital before generating any revenue, creating uncertainty around the project’s capital efficiency and timeline. This future-oriented anxiety proved far more powerful than the positive current earnings report.

Analyst Sentiment Provides a Glimmer of Hope

In the face of the sell-off, which drove the share price down to $40.30 at Friday’s close, several market analysts have maintained a surprisingly optimistic outlook. Rather than downgrading the stock, numerous firms actually raised their price targets following the earnings release. These experts point to Rocket Lab’s strong market position and growing institutional interest as reasons for continued confidence.

For shareholders, the situation now becomes a test of patience. The fundamental question for the coming months is whether Rocket Lab can rebuild market trust by flawlessly executing the revised Neutron schedule. While the sharp correction may have removed speculative excess from the stock’s valuation, the ultimate proof—a successful Neutron launch in 2026—remains on the horizon.